liraglutide

Generic: liraglutide

Labeler: meitheal pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name liraglutide
Generic Name liraglutide
Labeler meitheal pharmaceuticals inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 6 mg/mL

Manufacturer
Meitheal Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 71288-563
Product ID 71288-563_c4f6adef-1b2a-4e7c-b7a9-b19d4ed1df36
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218115
Listing Expiration 2027-12-31
Marketing Start 2025-04-02

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71288563
Hyphenated Format 71288-563

Supplemental Identifiers

RxCUI
897122
UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liraglutide (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number ANDA218115 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 3 SYRINGE, PLASTIC in 1 CARTON (71288-563-84) / 3 mL in 1 SYRINGE, PLASTIC
  • 2 SYRINGE, PLASTIC in 1 CARTON (71288-563-85) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (2)

Ingredients (1)

liraglutide (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "c4f6adef-1b2a-4e7c-b7a9-b19d4ed1df36", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["897122"], "spl_set_id": ["0efc3a89-211a-4496-baab-e8265e07de2b"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Meitheal Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3 SYRINGE, PLASTIC in 1 CARTON (71288-563-84)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "71288-563-84", "marketing_start_date": "20250402"}, {"sample": false, "description": "2 SYRINGE, PLASTIC in 1 CARTON (71288-563-85)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "71288-563-85", "marketing_start_date": "20250402"}], "brand_name": "Liraglutide", "product_id": "71288-563_c4f6adef-1b2a-4e7c-b7a9-b19d4ed1df36", "dosage_form": "INJECTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "71288-563", "generic_name": "liraglutide", "labeler_name": "Meitheal Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liraglutide", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "ANDA218115", "marketing_category": "ANDA", "marketing_start_date": "20250402", "listing_expiration_date": "20271231"}